Clinical trial
A Placebo Controlled, Double-Blind, Randomised Study to Assess Efficacy of Sublingual Immunotherapy in Patients With Grass Pollen Allergy Through Assessment of Its Immunological Effects on the Mucosal Tissue of the Nose.
NCT00150514 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Placebo Controlled, Double-Blind, Randomised Study to Assess Efficacy of Sublingual Immunotherapy in Patients With Grass Pollen Allergy Through Assessment of Its Immunological Effects on the Mucosal Tissue of the Nose.
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2002
- Completion date
- December 31, 2006
- Enrollment
- 38
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hayfever